Allogene Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Allogene Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q3 2018 to Q2 2024.
  • Allogene Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $6.44M, a 31.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.44M -$2.94M -31.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.16M -$4.23M -45.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $6.6M -$2.96M -30.9% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $9.58M +$198K +2.11% Sep 30, 2023 10-K 2024-03-14
Q2 2023 $9.38M +$444K +4.97% Jun 30, 2023 10-K 2024-03-14
Q1 2023 $9.39M +$347K +3.84% Mar 31, 2023 10-K 2024-03-14
Q4 2022 $9.56M +$3.75M +64.5% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $9.38M +$3.22M +52.2% Sep 30, 2022 10-K 2024-03-14
Q2 2022 $8.94M +$3.11M +53.3% Jun 30, 2022 10-K 2024-03-14
Q1 2022 $9.04M +$2.77M +44.1% Mar 31, 2022 10-K 2024-03-14
Q4 2021 $5.82M +$646K +12.5% Dec 31, 2021 10-K/A 2024-03-14
Q3 2021 $6.16M +$3.89M +171% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $5.83M +$3.67M +170% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $6.28M +$1.6M +34.2% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $5.17M +$551K +11.9% Dec 31, 2020 10-K 2022-02-23
Q3 2020 $2.27M -$831K -26.8% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $2.16M -$78K -3.49% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $4.68M +$4.24M +982% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $4.62M +$4.37M +1793% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.11M +$798K +34.6% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $2.24M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $432K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $244K Dec 31, 2018 10-K 2020-02-27
Q3 2018 $2.31M Sep 30, 2018 10-Q 2018-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.